METTL3-mediated m6A modification of the 5’UTR and 3’UTR of PBX1 mRNA promotes the expression of PBX1 mRNA by maintaining its stability, subsequently promoting the malignant progression of GC. Here, METTL3 is linked to gastric cancer.